"Es un cambio de paradigma o de enfoque que se centra en la prdida de masa grasa y no en el objetivo de prdida de peso en una balanza y que se centra en las complicaciones de la obesidad a la hora de elegir el tratamiento", seala este experto en SMC Espaa
But its a long-term play: Payers must analyze and establish longer-term ROI Even if payers actively want to keep up with the wave of demand for GLP-1s to treat obesity, they ultimately must convince plan sponsors to buy in
And to make money off this right now, Abbott introduced a line of ready to drink protein shakes geared at people taking drugs like Ozempic
Remember: muscle is the most metabolically active tissue in your body
Badulescu S, Tabassum A, Le GH, Wong S, Phan L, Gill H, et al